These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3115788)
1. A hypothesis on the etiology of malignant melanoma: the role of chemicals interfering with melanin synthesis. Morpurgo G; Maggini M Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1213-5. PubMed ID: 3115788 [No Abstract] [Full Text] [Related]
2. PCB? and melanoma. Lawrence C N Engl J Med; 1977 Jan; 296(2):108. PubMed ID: 401456 [No Abstract] [Full Text] [Related]
3. Likelihood-ratio testing as a diagnostic method for small-sample regressions. Greenland S Ann Epidemiol; 1992 May; 2(3):311-6. PubMed ID: 1342281 [No Abstract] [Full Text] [Related]
4. Cancer mortality among electric utility workers exposed to polychlorinated biphenyls. Loomis D; Browning SR; Schenck AP; Gregory E; Savitz DA Occup Environ Med; 1997 Oct; 54(10):720-8. PubMed ID: 9404319 [TBL] [Abstract][Full Text] [Related]
10. Levodopa administration and multiple primary cutaneous melanomas. Bernstein JE; Medenica M; Soltani K; Solomon A; Lorincz AL Arch Dermatol; 1980 Sep; 116(9):1041-44. PubMed ID: 7416757 [TBL] [Abstract][Full Text] [Related]
11. Organic chemicals and malignant melanoma. Wright WE; Peters JM; Mack TM Am J Ind Med; 1983; 4(4):577-81. PubMed ID: 6869382 [TBL] [Abstract][Full Text] [Related]
12. [Letter: Malignant melanoma during treatment with levodopa]. Pelfréne AF Nouv Presse Med; 1975 May; 4(18):1365. PubMed ID: 1153302 [No Abstract] [Full Text] [Related]
13. Notification of workers about an excess of malignant melanoma: a case study. Mazzuckelli LF; Schulte PA Am J Ind Med; 1993 Jan; 23(1):85-91. PubMed ID: 8422064 [TBL] [Abstract][Full Text] [Related]
14. Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature. Pfützner W; Przybilla B J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):332-6. PubMed ID: 9270541 [TBL] [Abstract][Full Text] [Related]
15. Levodopa and melanoma: three cases and review of literature. Rampen FH J Neurol Neurosurg Psychiatry; 1985 Jun; 48(6):585-8. PubMed ID: 4009196 [TBL] [Abstract][Full Text] [Related]
16. Melanoma and levodopa. Rampen F J Am Acad Dermatol; 1998 May; 38(5 Pt 1):782-4. PubMed ID: 9591833 [No Abstract] [Full Text] [Related]
17. Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature. Kochar AS Am J Med; 1985 Jul; 79(1):119-21. PubMed ID: 4014296 [TBL] [Abstract][Full Text] [Related]
18. [Malignant melanoma and L-dopa. Review of literature on the problem of causal relationship]. Happle Fortschr Med; 1974 Sep; 92(27):1065-6. PubMed ID: 4457419 [No Abstract] [Full Text] [Related]
19. [Melanoma as a possible complication of the treatment of parkinsonism with L-dopa preparations (review of the literature)]. Kande'l EI Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(9):126-7. PubMed ID: 2692357 [No Abstract] [Full Text] [Related]
20. [Melanin tumors induced in golden hamsters by per os administration of a single dose of 9,10-dimethyl-1,2-benzanthracene]. Aubert C; Prade M; Bohuon C Ann Dermatol Syphiligr (Paris); 1971; 98(5):515-7. PubMed ID: 5142890 [No Abstract] [Full Text] [Related] [Next] [New Search]